文献速递神经创伤神经重症

新型冠状病毒肺炎疫情期间创伤性脑损伤的管理——即刻结局的病例匹配对照分析

Managing Traumatic Brain Injury During the Coronavirus Disease 2019 Pandemic-A Case-Matched Controlled Analysis of Immediate Outcomes.
PubMed 文献 · World Neurosurg · 2022-05-25

本研究为回顾性病例对照研究,将2020年3月24日至11月30日疫情期间收治的118例创伤性脑损伤患者与2020年3月前收治的年龄和格拉斯哥昏迷评分匹配的118例对照进行比较。结果显示疫情期间组住院时间、麻醉诱导时间和手术时长更长,发热和肺炎发生率更高,但格拉斯哥结局扩展评分和死亡率两组相似。作者认为疫情期间遵循的指南在管理创伤性脑损伤患者方面有效。

要点

  • 疫情期间组住院时间8天 vs 对照组5天(P<0.001)。
  • 疫情期间组发热50% vs 对照组26.3%,肺炎27.1% vs 1.7%(均P<0.001)。
  • 两组死亡率18.6% vs 14.4%(P=0.42),结局评分相似。

核心结论

  • 疫情期间管理的创伤性脑损伤患者结局与本中心疫情前匹配患者相似。
  • 作者认为疫情期间遵循的指南在管理创伤性脑损伤患者方面有效。
  • 该模型可作为未来大流行波次中有效管理创伤性脑损伤患者而不损害结局的指南。

研究设计与样本

  • 回顾性病例对照研究,将2020年3月24日至2020年11月30日疫情期间收治的创伤性脑损伤患者(A组)与2020年3月前收治的年龄和格拉斯哥昏迷评分匹配的对照(B组)进行比较。
  • 每组匹配患者总数为118例。

主要发现

  • 住院时间A组8天 vs B组5天(P<0.001)。
  • 从急诊室到手术室的转运时间A组150分钟 vs B组97分钟(P=0.271)。
  • 麻醉诱导时间A组75分钟 vs B组45分钟(P=0.002)。
  • 手术时长A组275分钟 vs B组180分钟(P=0.002)。
  • 发热发生率A组50% vs B组26.3%(P<0.001),肺炎发生率A组27.1% vs B组1.7%(P<0.001)。

临床怎么用

  • 作者认为疫情期间遵循的指南在管理创伤性脑损伤患者方面有效,该模型可作为未来大流行波次的指南。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The primary objective of this study was to evaluate the outcome of patients with traumatic brain injury (TBI) during the coronavirus disease 2019 (COVID-19) pandemic and to compare their outcome with case-matched controls from the prepandemic phase. METHODS: This is a retrospective case-control study in which all patients with TBI admitted during COVID-19 pandemic phase (Arm A) from March 24, 2020 to November 30, 2020 were matched with age and Glasgow Coma Scale score-matched controls from the patients admitted before March 2020 (Arm B). RESULTS: The total number of patients matched in each arm was 118. The length of hospital stay (8 days vs. 5 days; P < 0.001), transit time from emergency room to operation room (150 minutes vs. 97 minutes; P = 0.271), anesthesia induction time (75 minutes vs. 45 minutes; P = 0.002), and operative duration (275 minutes vs. 180 minutes; P = 0.002) were longer in arm A. Although the incidence of fever and pneumonia was significantly higher in arm A than in arm B (50% vs. 26.3%, P < 0.001 and 27.1% vs. 1.7%, P < 0.001, respectively), outcome (Glasgow Outcome Scale-Extended) and mortality (18.6% vs. 14.4% respectively; P = 0.42) were similar in both the groups. CONCLUSIONS: The outcome of the patients managed for TBI during the COVID-19 pandemic was similar to matched patients with TBI managed at our center before the onset of the COVID-19 pandemic. This finding suggests that the guidelines followed during the COVID-19 pandemic were effective in dealing with patients with TBI. This model can serve as a guide for any future pandemic waves for effective management of patients with TBI without compromising their outcome.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Alam I, Garg K, Raheja A, et al. Managing Traumatic Brain Injury During the Coronavirus Disease 2019 Pandemic-A Case-Matched Controlled Analysis of Immediate Outcomes. World Neurosurg. 2022. PMID: 35643408. doi:10.1016/j.wneu.2022.05.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。